Dead or alive? Is viability alone enough?

Cell count and viability in cell therapy

Presenter: Greg Fendley, PhD / Senior Field Application Scientist 

A reliable cell count and viability is critical to the development and release of cell therapy products.

In this webinar, we look at: 

  • The history of cell therapy, how it has emerged as a driver in the biopharma industry
  • Factors to consider when assessing the overall health and viability of a cell therapy product
  • Different modes of cell death, describe the pathways involved and identify the systematic events that lead a cell to the point of no return
  • Automated methods and cell-based assays to measure cell death
  • How dying cells may initially register as viable, yet become functionally dead in downstream processes


Watch our webinar “Dead or alive? Is viability alone enough?” below


We welcome and encourage blog users to leave comments. ChemoMetec reserves the right to moderate all comments and delete any that could be determined as i) irrelevant, ii) containing spam, iii) containing profanity, iv) deemed offensive or v) containing questionable content. We reserve the right to withhold any comment from being published. ChemoMetec is not responsible for the content in comments, which represent solely the views of the commenter.


Leave a comment

Your email address will not be published. Required fields are marked *